SHANNA LANGFORD: Open Payments
NPI 1992197222 · LAWRENCEBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,076 in 110 payments from 27 companies in 2025. Trend: 2023 $1,461 · 2024 $2,472 · 2025 $2,076
Food & beverage: $2,076
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $351 |
| ABBVIE INC. | 20 | $345 |
| Novo Nordisk Inc | 15 | $326 |
| PFIZER INC. | 11 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $117 |
| Lilly USA, LLC | 6 | $111 |
| Verona Pharma, Inc. | 3 | $77 |
| Amgen Inc. | 5 | $76 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $64 |
Products named: AIRSUPRA, Ozempic, QULIPTA, VRAYLAR, CAPLYTA, FARXIGA, Rybelsus, Ohtuvayre.
Industry payments across KY — which companies pay providers there.
